# A Study of Participants With Advanced Non-Small Cell Lung Cancer Treated With Nivolumab in France After at Least One Prior Chemotherapy-based Treatment by Lung Initiative on Sequence Therapy

> **NCT04500535** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 535 (actual)

## Conditions studied

- Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04500535
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-28
- **Primary completion:** 2025-04-18
- **Final completion:** 2025-04-18
- **Target enrollment:** 535 (ACTUAL)
- **Last updated:** 2025-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04500535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04500535, "A Study of Participants With Advanced Non-Small Cell Lung Cancer Treated With Nivolumab in France After at Least One Prior Chemotherapy-based Treatment by Lung Initiative on Sequence Therapy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04500535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*